US 8580802
Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases
granted A61PA61P11/06A61P17/14
Quick answer
US patent 8580802 (Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P11/06, A61P17/14, A61P19/08, A61P21/00